Overview

Fertility Preservation in Breast Cancer Patients

Status:
Active, not recruiting

Trial end date:
2022-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate efficiency and safety of controlled ovarian stimulation (COS) associated with an aromatase inhibitor (letrozole) for fertility preservation in breast cancer patients.

Phase:

Phase 4

Details

Lead Sponsor:

Erasme University Hospital

Treatments:

Letrozole